<DOC>
	<DOCNO>NCT01579097</DOCNO>
	<brief_summary>The objective study assess safety efficacy Oliclinomel N4 compare compound ternary parenteral nutrition ( PN ) admixtures delivery PN hospitalize adult oral enteral nutrition possible , insufficient , contraindicate .</brief_summary>
	<brief_title>Comparative Phase 3 Trial Assess Safety Efficacy Triple-chamber Parenteral Nutrition Formulation</brief_title>
	<detailed_description />
	<criteria>Inpatient hospitalize &lt; 14 day prior enrollment Requires PN oral enteral nutrition possible , insufficient , contraindicate Has capability complete least 5 day study treatment ( i.e. , PN ) Has useable peripheral vein delivery intravenous ( IV ) PN Has life expectancy &lt; 6 day initiation study treatment , opinion Investigator Known hypersensitivity component either investigational study treatment Use prohibit medication ( e.g . glucocorticosteroids antitumor chemotherapeutic agent ) within 30 day prior enrollment Known serious clinically significant condition would preclude participation study Known chronic active hepatitis , elevate liver function test Known history human immunodeficiency virus infection Known severe dyslipidemia , severe hyperglycemia , clinically significant abnormality plasma electrolyte Known pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>( PN ) Parenteral nutrition</keyword>
	<keyword>oral/enteral possible</keyword>
</DOC>